Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in European Children
2008-005791-27Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of Emerflu in influenza (3 arms), sponsored by Sanofi. Primary endpoint: Safety profile: injection site reactions and systemic events. Started Jan 2009; status: completed.
02
Drugs
Emerflu
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-005791-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005791-27.